Where is EdiGene headquartered?

EdiGene is located in Changping, beijing municipality.

Who invested in EdiGene?

EdiGene has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for EdiGene?

EdiGene closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

edigene.com

EdiGene

EdiGene is a China-based biotechnology company that develops and commercializes novel therapeutics for the treatment of genetic and cancer diseases.

Business Model:

Revenue: $1.8M

Employees: 51-200

Geographic Data

Address: 22 Science Park Road

City: Changping

State: beijing municipality

Zip: 102202

Country: CN

Financial Info

Stage:

series b

Raised Last:

$62M

Raised Total:

$169M

Social

Facebook

Twitter

Crunchbase

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

EdiGene is a China-based biotechnology company that develops and commercializes novel therapeutics for the treatment of genetic and cancer diseases.

Contact Phone:

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2017	Series A	1	$15M	Fujifilm Fujifilm
2/2019	Series A	3	$10M	Green Pine Capital Partners Lilly Asia Ventures IDG Capital Green Pine Capital Partners
4/2021	Series B		$62M	Loyal Valley Capital BioTrack Capital Sherpa Healthcare Partners IDG Capital Lilly Asia Venture 3H Health Investment Huagai Capital Sequoia Capital China, Alwin Capital Kunlun Capital
8/2018	Pre-Series B		$15M	Lilly Asia Ventures Huagai Capital IDG Capital WI Harper Group
10/2020	Series B		$0	3H Health Investment KUNLUN Sequoia Capital China Lilly Asia Ventures IDG Capital Huagai Capital Green Pine Capital Partners Alwin Capital 3H Health Investment KUNLUN Sequoia Capital China Lilly Asia Ventures IDG Capital Huagai Capital Green Pine Capital Partners Alwin Capital
9/2019	Pre-Series B		$11M	IDG Capital Lilly Asia Ventures
4/2021	Series B	10	$61.6M	3H Health Investment Alwin Capital BioTrack Capital Huagai Capital IDG Capital Kunlun Capital Lilly Asia Ventures Loyal Valley Capital Sequoia Capital China Sherpa Venture Capital 3H Health Investment Alwin Capital BioTrack Capital Huagai Capital IDG Capital Kunlun Capital Lilly Asia Ventures Loyal Valley Capital Sequoia Capital China Sherpa Venture Capital
10/2016	Series A	2	-	IDG Capital WI Harper Group IDG Capital WI Harper Group
9/2019	Series A	2	$11.5M	Lilly Asia Ventures IDG Capital
8/2018	Series A	4	$14.5M	Lilly Asia Ventures WI Harper Group IDG Capital Huagai Capital Lilly Asia Ventures
10/2020	Series B	8	$67M	3H Health Investment Sequoia Capital China Alwin Capital Kunlun Capital IDG Capital Lilly Asia Venture Huagai Capital Green Pine Capital Partners 3H Health Investment
10/2016	Series A	2	-	IDG Capital IDG Capital

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details